These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14617342)

  • 1. Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan.
    Wu KH; Chu SL; Chang JG; Shih MC; Peng CT
    Transfus Med; 2003 Oct; 13(5):311-4. PubMed ID: 14617342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The incidence of irregular antibodies in pregnancy: a prospective study in the region of the 's-Hertogenbosch].
    de Vrijer B; Harthoorn-Lasthuizen EJ; Oosterbaan HP
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2523-7. PubMed ID: 10627755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-sectional study of haemolytic disease of the newborn in Uganda.
    Dhabangi A; Nankunda J; Okaba V; Nakubulwa S; Hume HA; Dzik WH; Heddle NM
    Vox Sang; 2022 Dec; 117(12):1398-1404. PubMed ID: 36342344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemolytic disease of the newborn due to anti-M.
    Duguid JK; Bromilow IM; Entwistle GD; Wilkinson R
    Vox Sang; 1995; 68(3):195-6. PubMed ID: 7625079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
    van Dijk BA; Hirasing RA; Overbeeke MA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn. Group for the Study of Protective Maternal HLA Antibodies in the Clinical Course of HDN.
    Neppert J; v Witzleben-Schürholz E; Zupanska B; Bartz L; Greve O; Eichler H; Kerowgan M; Wichmann MG
    Eur J Haematol; 1999 Aug; 63(2):120-5. PubMed ID: 10480291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.
    Bennardello F; Curciarello G
    Blood Transfus; 2013 Oct; 11(4):518-27. PubMed ID: 23867179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemolytic disease of the newborn infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: thirty years of experience.
    Moncharmont P; Juron Dupraz F; Vignal M; Rigal D; Meyer F; Debeaux P
    Arch Gynecol Obstet; 1991; 248(4):175-80. PubMed ID: 1910321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of hemolytic disease of the newborn due to anti-Dib antibodies.
    Uchikawa M; Shibata Y; Tohyama H; Mori H; Aisaka K; Nakagawa M
    Vox Sang; 1982 Feb; 42(2):91-2. PubMed ID: 7199783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemolytic disease of newborn.
    Narang A; Jain N
    Indian J Pediatr; 2001 Feb; 68(2):167-72. PubMed ID: 11284186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case for comprehensive antenatal screening for blood group antibodies.
    Anwar M; Ali N; Khattak MF; Raashid Y; Karamat KA
    J Pak Med Assoc; 1999 Oct; 49(10):246-8. PubMed ID: 10647230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy--a review of cases from 1997 to 2001.
    Lee CK; Ma ES; Tang M; Lam CC; Lin CK; Chan LC
    Transfus Med; 2003 Aug; 13(4):227-31. PubMed ID: 12880393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrops foetalis caused by anti-Mur in first pregnancy--a case report.
    Wu KH; Chang JG; Lin M; Shih MC; Lin H; Lee CC; Peng CT; Tsai CH
    Transfus Med; 2002 Oct; 12(5):325-7. PubMed ID: 12383339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
    Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
    Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia.
    Ziprin JH; Payne E; Hamidi L; Roberts I; Regan F
    Transfus Med; 2005 Feb; 15(1):57-60. PubMed ID: 15713130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemolytic disease of the newborn in Western Australia 1974 to 1976.
    Vieira BI; Murdock CJ; Hendry PJ; Stanley F; Davey MG
    Aust N Z J Obstet Gynaecol; 1980 May; 20(2):69-72. PubMed ID: 6774705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
    Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
    Front Immunol; 2021; 12():698541. PubMed ID: 35003054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.